Walmart to deliver US prescription medications in as soon as 30 minutes
Adds new details from Walmart spokesperson in paragraphs 6- 10
Oct 22 (Reuters) - U.S. retailer Walmart WMT.N on Tuesday said it will start delivering prescription medicines and medication refills along with groceries and other items as a single order within 30 minutes, upping the ante in its delivery competition against Amazon Inc AMZN.O.
Walmart's move comes a couple of weeks after Amazon announced plans to open pharmacies offering same-day delivery options across 20 new U.S. cities in 2025. It is also an extension of Walmart's previous efforts to mail prescription medications which typically took at least five to seven business days.
The speedier prescription delivery service would compete against other same-day pharmacy delivery offerings provided by retailers such as CVS Health CVS.N and Walgreens WBA.O.
Walmart, which operates 4,600 U.S. pharmacies and 3,000 vision centers across the country, said its pharmacy delivery service would be free for members of its $98 per year Walmart Plus membership program while non-members need to pay $9.95.
The service will be available to customers in 49 states by the end of January next year. Currently, customers in six states, namely Arkansas, Missouri, New York, Nevada, South Carolina and Wisconsin can usethe service.
Walmart said it decided to launch the service after more than half of respondents in an internal consumer research survey expressed a desire to have prescription medications delivered along with groceries and other items in one order.
Walmart will use drivers from its Spark Driver gig-delivery network to make some of these speedy deliveries, a company spokesman said in an email. The company also employs other options to deliver orders within 30 minutes, such as drones.
Barring controlled substances, refrigeration items and Medicare Part B products, such as wheelchairs and oxygen containers, all medications are delivery eligible.
When customers place a pharmacy delivery order through Walmart's app or website, they must agree to terms allowing Walmart's pharmacy staff to contact their physicians and provide counseling by phone, the spokesperson said.
A delivery timeframe does not begin until prescriptions are authorized by a customer's physician. Once approved, customers can add the medications to their cart and pick either same-day, on-demand or express delivery timeframe, the spokesperson added.
This prescription delivery service is Walmart's latest effort to focus on its pharmacy network, following its decision toclose51 health clinics and its virtual healthcare operations in April.
Reporting by Siddharth Cavale in New York and Ananya Mariam Rajesh in Bengaluru; Editing by Shreya Biswas and Alistair Bell
Aset Terkait
Berita Terbaru
Pengungkapan: Entitas XM Group menyediakan layanan khusus eksekusi dan akses ke Fasilitas Trading Online kami, yang memungkinkan Anda untuk melihat dan/atau menggunakan konten yang tersedia pada atau melalui situs, yang tidak untuk mengubah atau memperluas, serta tidak mengubah atau memperluas hal tersebut. Akses dan penggunaan ini selalu sesuai dengan: (i) Syarat dan Ketentuan; (ii) Peringatan Risiko; dan (iii) Pengungkapan Penuh. Oleh karena itu, konten disediakan hanya sebagai informasi umum. Anda juga harus ketahui bahwa konten Fasilitas Trading Online kami bukan sebagai ajakan atau tawaran untuk untuk melakukan transaksi apa pun di pasar finansial. Trading di pasar finansial mana pun melibatkan tingkat risiko yang signifikan pada modal Anda.
Semua materi yang diterbitkan di Fasilitas Trading Online kami hanya untuk tujuan edukasi/informasi dan tidak boleh mengandung nasihat dan rekomendasi finansial, pajak investasi atau trading, catatan harga trading kami, penawaran, permintaan, transaksi dalam instrumen finansial apa pun atau promo finansial untuk Anda yang tidak diminta.
Konten pihak ketiga apa pun, serta konten yang disiapkan oleh XM, seperti opini, berita, riset, analisis, harga, informasi lain atau link ke situs pihak ketiga yang tersedia "sebagaimana adanya", sebagai komentar pasar umum dan bukan menjadi nasihat investasi. Sejauh konten apa pun ditafsirkan sebagai penelitian investasi, Anda harus memperhatikan dan menerima bahwa konten tersebut tidak dimaksudkan dan belum disiapkan sesuai dengan persyaratan hukum yang dirancang untuk mempromosikan kemandirian riset investasi dan dengan demikian akan dianggap sebagai komunikasi pemasaran di bawah hukum dan peraturan yang relevan. Mohon dipastikan bahwa Anda telah membaca dan memahami Notifikasi pada Riset Investasi Non-Independen dan Peringatan Risiko kami mengenai informasi di atas, yang dapat diakses disini.
